Kynurenines, Neuropsychiatric Symptoms, and Cognitive Prognosis in Patients with Mild Dementia
Introduction: Circulating tryptophan (Trp) and its downstream metabolites, the kynurenines, are potentially neuroactive. Consequently, they could be associated with neuropsychiatric symptoms and cognitive prognosis in patients with dementia. Objective: The objective of this study was to assess assoc...
Main Authors: | Stein-Erik Hafstad Solvang, Jan Erik Nordrehaug, Dag Aarsland, Johannes Lange, Per Magne Ueland, Adrian McCann, Øivind Midttun, Grethe S Tell, Lasse Melvaer Giil |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-09-01
|
Series: | International Journal of Tryptophan Research |
Online Access: | https://doi.org/10.1177/1178646919877883 |
Similar Items
-
Correction: Plasma kynurenines and prognosis in patients with heart failure.
by: Anders Lund, et al.
Published: (2020-01-01) -
Plasma kynurenines and prognosis in patients with heart failure.
by: Anders Lund, et al.
Published: (2020-01-01) -
Differentiating traits and states identifies the importance of chronic neuropsychiatric symptoms for cognitive prognosis in mild dementia
by: Lasse M. Giil, et al.
Published: (2021-01-01) -
Kynurenine pathway metabolites in Alzheimer's disease.
by: Giil, L, et al.
Published: (2017) -
Does pain, psychological distress and deteriorated family economy follow traumatic amputation among war casualties? A retrospective, cross-sectional study from Gaza
by: Lasse Melvaer Giil
Published: (2019-06-01)